195 related articles for article (PubMed ID: 32062621)
1. Integration of read-across and artificial neural network-based QSAR models for predicting systemic toxicity: A case study for valproic acid.
Hisaki T; Kaneko MAN; Hirota M; Matsuoka M; Kouzuki H
J Toxicol Sci; 2020; 45(2):95-108. PubMed ID: 32062621
[TBL] [Abstract][Full Text] [Related]
2. Development of QSAR models using artificial neural network analysis for risk assessment of repeated-dose, reproductive, and developmental toxicities of cosmetic ingredients.
Hisaki T; Aiba Née Kaneko M; Yamaguchi M; Sasa H; Kouzuki H
J Toxicol Sci; 2015 Apr; 40(2):163-80. PubMed ID: 25786522
[TBL] [Abstract][Full Text] [Related]
3. Do Similar Structures Have Similar No Observed Adverse Effect Level (NOAEL) Values? Exploring Chemoinformatics Approaches for Estimating NOAEL Bounds and Uncertainties.
Yang C; Rathman JF; Magdziarz T; Mostrag A; Kulkarni S; Barton-Maclaren TS
Chem Res Toxicol; 2021 Feb; 34(2):616-633. PubMed ID: 33296179
[TBL] [Abstract][Full Text] [Related]
4. Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties.
Batke M; Gütlein M; Partosch F; Gundert-Remy U; Helma C; Kramer S; Maunz A; Seeland M; Bitsch A
Front Pharmacol; 2016; 7():321. PubMed ID: 27708580
[TBL] [Abstract][Full Text] [Related]
5. Quantitative read-across structure-activity relationship (q-RASAR): A novel approach to estimate the subchronic oral safety (NOAEL) of diverse organic chemicals in rats.
Ghosh S; Roy K
Toxicology; 2024 Jun; 505():153824. PubMed ID: 38705560
[TBL] [Abstract][Full Text] [Related]
6. In Silico Models for Repeated-Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs.
Pizzo F; Benfenati E
Methods Mol Biol; 2016; 1425():163-76. PubMed ID: 27311467
[TBL] [Abstract][Full Text] [Related]
7. High Throughput Read-Across for Screening a Large Inventory of Related Structures by Balancing Artificial Intelligence/Machine Learning and Human Knowledge.
Yang C; Rathman JF; Mostrag A; Ribeiro JV; Hobocienski B; Magdziarz T; Kulkarni S; Barton-Maclaren T
Chem Res Toxicol; 2023 Jul; 36(7):1081-1106. PubMed ID: 37399585
[TBL] [Abstract][Full Text] [Related]
8. In Silico Model for Developmental Toxicity: How to Use QSAR Models and Interpret Their Results.
Marzo M; Roncaglioni A; Kulkarni S; Barton-Maclaren TS; Benfenati E
Methods Mol Biol; 2016; 1425():139-61. PubMed ID: 27311466
[TBL] [Abstract][Full Text] [Related]
9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo Models for Sub-Chronic Repeated-Dose Toxicity: Systemic and Organ-Specific Toxicity.
Selvestrel G; Lavado GJ; Toropova AP; Toropov AA; Gadaleta D; Marzo M; Baderna D; Benfenati E
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743059
[TBL] [Abstract][Full Text] [Related]
11. Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose.
Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
Regul Toxicol Pharmacol; 2004 Dec; 40(3):185-206. PubMed ID: 15546675
[TBL] [Abstract][Full Text] [Related]
12. Toxicological assessment of epinephrine and norepinephrine by analog approach.
Aydın A; Tugcu G
Food Chem Toxicol; 2018 Aug; 118():726-732. PubMed ID: 29913233
[TBL] [Abstract][Full Text] [Related]
13. Computational Modeling of Human Serum Albumin Binding of Per- and Polyfluoroalkyl Substances Employing QSAR, Read-Across, and Docking.
Gallagher A; Kar S; Sepúlveda MS
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513249
[TBL] [Abstract][Full Text] [Related]
14. Chronic oral LOAEL prediction by using a commercially available computational QSAR tool.
Rupp B; Appel KE; Gundert-Remy U
Arch Toxicol; 2010 Sep; 84(9):681-8. PubMed ID: 20224925
[TBL] [Abstract][Full Text] [Related]
15. Quantitative in vitro to in vivo extrapolation for developmental toxicity potency of valproic acid analogues.
Chang X; Palmer J; Lumen A; Lee UJ; Ceger P; Mansouri K; Sprankle C; Donley E; Bell S; Knudsen TB; Wambaugh J; Cook B; Allen D; Kleinstreuer N
Birth Defects Res; 2022 Oct; 114(16):1037-1055. PubMed ID: 35532929
[TBL] [Abstract][Full Text] [Related]
16.
Basant N; Gupta S; Singh KP
Toxicol Res (Camb); 2016 May; 5(3):773-787. PubMed ID: 30090388
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel uncertainty factors and thresholds of toxicological concern for health hazard and risk assessment: Application to cleaning product ingredients.
Wang Z; Scott WC; Williams ES; Ciarlo M; DeLeo PC; Brooks BW
Environ Int; 2018 Apr; 113():357-376. PubMed ID: 29452931
[TBL] [Abstract][Full Text] [Related]
18. In Silico Models for Repeated-Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs.
Pizzo F; Gadaleta D; Benfenati E
Methods Mol Biol; 2022; 2425():241-258. PubMed ID: 35188636
[TBL] [Abstract][Full Text] [Related]
19. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
[TBL] [Abstract][Full Text] [Related]
20. Value and limitation of structure-based profilers to characterize developmental and reproductive toxicity potential.
Manganelli S; Schilter B; Scholz G; Benfenati E; Lo Piparo E
Arch Toxicol; 2020 Mar; 94(3):939-954. PubMed ID: 32100055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
